Membrane orientation of the human papillomavirus type 16 E5 oncoprotein

Journal of Virology

Volumn 84, Issue 4, 2010, Pages 1696-1703

  Krawczyk, Ewa ^a   Suprynowicz, Frank A ^a   Sudarshan, Sawali R ^a   Schlegel, Richard ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; DETERGENT; DIGITONIN; ENVELOPE PROTEIN; ONCOPROTEIN; PROTEIN E5; SAPONIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL STRAIN COS1; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; HYDROPHILICITY; HYDROPHOBICITY; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UTERINE CERVIX; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CERVIX UTERI; COS CELLS; ENDOPLASMIC RETICULUM; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTRACELLULAR MEMBRANES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECOMBINANT PROTEINS; TRANSFECTION;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 75449098833     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01968-09     Document Type: Article

References (44)

1. Ashrafi, G. H., M. Haghshenas, B. Marchetti, and M. S. Campo. 2006. E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int. J. Cancer 119: 2105-2112.
2. Bae, I., J. K. Rih, H. J. Kim, H. J. Kang, B. Haddad, A. Kirilyuk, S. Fan, M. L. Avantaggiati, and E. M. Rosen. 2005. BRCA1 regulates gene expression for orderly mitotic progression. Cell Cycle 4:1641-1666.
3. Baege, A. C., A. Berger, R. Schlegel, T. Veldman, and R. Schlegel. 2002. Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity. Am. J. Pathol. 160:1251-1257.
4. Bergeron, J. J., M. B. Brenner, D. Y. Thomas, and D. B. Williams. 1994. Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem. Sci. 19:124-128.
5. Burkhardt, A., M. Willingham, C. Gay, K. T. Jeang, and R. Schlegel. 1989. The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology 170:334-339.
6. Chen, S. L., S. T. Lin, T. C. Tsai, W. C. Hsiao, and Y. P. Tsao. 2006. ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein. Oncogene 26:42-53.
7. Conrad, M., V. J. Bubb, and R. Schlegel. 1993. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J. Virol. 67:6170-6178.
8. Crusius, K., E. Auvinen, B. Steuer, H. Gaissert, and A. Alonso. 1998. The human papillomavirus type 16 E5 protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. Exp. Cell Res. 241:76-84.
9. Deane, R., W. Schäfer, H. P. Zimmermann, L. Mueller, D. Görlich, S. Prehn, H. Ponstingl, and F. R. Bischoff. 1997. Ran-binding protein 5 (RanBP5) is related to the nuclear transport factor importin-β but interacts differently with RanBP1. Mol. Cell. Biol. 17:5087-5096.
10. Disbrow, G. L., I. Sunitha, C. C. Baker, J. Hanover, and R. Schlegel. 2003. Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology 311:105-114.
11. Disbrow, G. L., J. Hanover, and R. Schlegel. 2005. Endoplasmic reticulumlocalized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. J. Virol. 79:5839-5846.
12. Fehrmann, F., and L. A. Laimins. 2003. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 22: 5201-5207.
13. Genther Williams, S. M., G. L. Disbrow, R. Schlegel, D. Lee, D. W. Threadgill, and P. F. Lambert. 2005. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res. 65:6534-6542.
14. Gieswein, C. E., F. J. Sharom, and A. G. Wildeman. 2003. Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions. Virology 313:415-426.
15. Giuliano, A. R., G. Tortolero-Luna, E. Ferrer, A. N. Burchell, S. de Sanjose, S. K. Kjaer, N. Muñoz, M. Schiffman, and F. X. Bosch. 2008. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 26S:K17-K28.
16. Gruener, M., I. G. Bravo, F. Momburg, A. Alonso, and P. Tomakidi. 2007. The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells. Virol. J. 4:116-130.
17. Hu, L., K. Plafker, V. Vorozhko, R. E. Zuna, M. H. Hanigan, G. J. Gorbsky, S. M. Plafker, P. C. Angeletti, and B. P. Ceresa. 2009. Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion. Virology 384: 125-134.
18. Hu, L., and B. P. Ceresa. 26 August 2009, posting date. Characterization of the plasma membrane localization and orientation of HPV16 E5 for cell-cell fusion. Virology [Epub ahead of print.] doi:10.1016/j.virol.2009. 07.034.
19. Krawczyk, E., J. A. Hanover, R. Schlegel, and F. A. Suprynowicz. 2008. Karyopherin β3: a new cellular target for the HPV-16 E5 oncoprotein. Biochem. Biophys. Res. Commun. 371:684-688.
20. Krawczyk, E., F. A. Suprynowicz, X. Liu, Y. Dai, D. P. Hartmann, J. Hanover, and R. Schlegel. 2008. Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. Am. J. Pathol. 173:682-688.
21. Lazarczyk, M., C. Pons, J. A. Mendoza, P. Cassonnet, Y. Jacob, and M. Favre. 2008. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J. Exp. Med. 205:35-42.
22. Lewis, C., M. F. Baro, M. Marques, M. Grüner, A. Alonso, and I. G. Bravo. 2008. The first hydrophobic region of the HPV16 E5 protein determines protein cellular location and facilitates anchorage-independent growth. Virol. J. 5:30-39.
23. Lim, P. S., A. B. Jenson, L. Cowsert, Y. Nakai, L. Y. Lim, X. W. Jin, and J. P. Sundberg. 1990. Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. J. Infect. Dis. 162:1263-1269.
24. Liu, J., N. Xiao, and B. D. DeFranco. 1999. Use of digitonin-permeabilized cells in studies of steroid receptor subnuclear trafficking. Methods 19:403-409.
25. Longworth, M. S., and L. A. Laimins. 2004. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68:362-372.
26. Miller, K., J. Beardmore, H. Kanety, J. Schlessinger, and C. R. Hopkins. 1986. Localization of the epidermal growth factor (EGF) receptor within the endosome of EGF-stimulated epidermoid carcinoma (A431) cells. J. Cell Biol. 102:500-509.
27. Miranda, M., and A. Sorkin. 2007. Regulation of receptors and transporters by ubiquitination: new insights into surprisingly similar mechanisms. Mol. Interv. 7:57-167.
28. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
29. Muñoz, N., X. Castellsagué, A. B. de González, and L. Gissmann. 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24(Suppl. 3):1-10.
30. Nath, R., C. A. Mant, B. Kell, J. Cason, and J. M. Bible. 2006. Analyses of variant human papillomavirus type-16 E5 proteins for their ability to induce mitogenesis of murine fibroblasts. Cancer Cell Int. 6:19-27.
31. Orth, G. 2008. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr. Top. Microbiol. Immunol. 321:59-83.
32. Pati, U. K. 1992. Novel vectors for expression of cDNA encoding epitopetagged proteins in mammalian cells. Gene 114:285-288.
33. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U. S. A. 90:8392-8396.
34. Perez, O. D., P. O. Krutzik, and G. P. Nolan. 2004. Flow cytometric analysis of kinase signaling cascade, p. 67-94. In T. S. Hawley and R. G. Hawley (ed.), Flow cytometry protocols, 2nd ed. Humana Press, Totowa, NJ.
35. Regan, J. A., and L. A. Laimins. 2008. Bap31 is a novel target of the human papillomavirus E5 protein. J. Virol. 82:10042-10051.
36. +-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. Oncogene 19:3727-3732.
37. Sparkowski, J., J. Anders, and R. Schlegel. 1994. Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants. J. Virol. 68:6120-6123.
38. Suprynowicz, F. A., G. L. Disbrow, V. Simic, and R. Schlegel. 2005. Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16? Virology 332:102-113.
39. Suprynowicz, F. A., G. L. Disbrow, E. Krawczyk, V. Simic, K. Lantzky, and R. Schlegel. 2008. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells. Oncogene 27:1071-1078.
40. Vindeløv, L. L., I. J. Christensen, and N. I. Nissen. 1983. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323-327.
41. Yang, D. H., A. G. Wildeman, and F. J. Sharom. 2003. Overexpression, purification, and structural analysis of the hydrophobic E5 protein from human papillomavirus type 16. Protein Expr. Purif. 30:1-10.
42. Yaseen, N. R., and G. Blobel. 1997. Cloning and characterization of human karyopherin β3. Proc. Natl. Acad. Sci. U. S. A. 94:4451-4456.
43. zur Hausen, H., and E.-M. de Villiers. 1994. Human papillomaviruses. Annu. Rev. Microbiol. 48:427-447.
44. zur Hausen, H. 2009. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 384:260-265.